ALNY position history
The shares of Alnylam Pharmaceuticals (ALNY) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 3,000 shares, $566K, 0.01% of portfolio
- 2021 Q4: 3,000 shares, $509K, 0.01% of portfolio
- 2022 Q1: 3,000 shares, $490K, <0.01% of portfolio
- 2022 Q2: 3,000 shares, $438K, <0.01% of portfolio
- 2022 Q3: 3,000 shares, $600K, 0.01% of portfolio
- 2022 Q4: 6,000 shares, $1.4M, 0.02% of portfolio, Add +100.0%
- 2023 Q1: 3,000 shares, $601K, 0.01% of portfolio, Reduce −50.0%
- 2023 Q2: 3,000 shares, $570K, 0.01% of portfolio
- 2023 Q3: 3,000 shares, $531K, 0.01% of portfolio
- 2023 Q4: 2,880 shares, $551K, 0.01% of portfolio, Reduce −4.0%
- 2024 Q1: 2,880 shares, $430K, <0.01% of portfolio
- 2024 Q2: 2,880 shares, $700K, 0.01% of portfolio
- 2024 Q3: 2,759 shares, $759K, 0.01% of portfolio, Reduce −4.2%
- 2024 Q4: 2,880 shares, $678K, <0.01% of portfolio, Add +4.4%
- 2025 Q1: 2,880 shares, $778K, <0.01% of portfolio
- 2025 Q2: 2,759 shares, $900K, 0.01% of portfolio, Reduce −4.2%
- 2025 Q3: 2,480 shares, $1.1M, 0.01% of portfolio, Reduce −10.1%
- 2025 Q4: 2,376 shares, $945K, 0.01% of portfolio, Reduce −4.2%
- 2026 Q1: 2,272 shares, $752K, <0.01% of portfolio, Reduce −4.4%
- 2026 Q2: 2,168 shares, $653K, <0.01% of portfolio, Reduce −4.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|